Animals
Lessons from dog lifespan therapeutics for their human companions.
The growing evidence that existing cardio-renal-metabolic therapies, such as GLP-1 receptor agonists and SGLT2 inhibitors, confer all-cause mortality benefits has positioned them as the first wave of potential…
Summary of earlier studies
Energy devices for facial aging linked to GLP-1 drugs: a review of ideas
This review proposes ideas for research on energy-based skin devices in people taking GLP-1 drugs. It does not show that any device is safe or works for this group.
People
Semaglutide may slow some biological aging clocks in adults with HIV
In a trial of 84 adults, semaglutide was linked to slower aging scores on several blood-based measures. This was an extra analysis not planned at the start, so it cannot prove the drug slows aging.